PALLOTTA, MARIA TERESA
 Distribuzione geografica
Continente #
NA - Nord America 2.991
EU - Europa 2.367
AS - Asia 2.280
SA - Sud America 329
Continente sconosciuto - Info sul continente non disponibili 279
AF - Africa 51
OC - Oceania 3
Totale 8.300
Nazione #
US - Stati Uniti d'America 2.884
SG - Singapore 988
IT - Italia 745
CN - Cina 360
HK - Hong Kong 307
VN - Vietnam 290
IE - Irlanda 282
BR - Brasile 230
FR - Francia 225
RU - Federazione Russa 214
DE - Germania 204
RO - Romania 179
FI - Finlandia 93
UA - Ucraina 91
GB - Regno Unito 82
IN - India 66
SE - Svezia 64
CA - Canada 55
KR - Corea 45
BE - Belgio 40
AR - Argentina 39
BD - Bangladesh 35
CZ - Repubblica Ceca 34
MX - Messico 29
NL - Olanda 26
TR - Turchia 25
JP - Giappone 24
CO - Colombia 19
IQ - Iraq 19
ID - Indonesia 17
VE - Venezuela 17
PK - Pakistan 16
PL - Polonia 16
ZA - Sudafrica 15
AT - Austria 14
CH - Svizzera 14
ES - Italia 14
EC - Ecuador 11
PH - Filippine 10
LT - Lituania 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AZ - Azerbaigian 7
CI - Costa d'Avorio 7
GR - Grecia 7
AE - Emirati Arabi Uniti 6
TN - Tunisia 6
IL - Israele 5
JO - Giordania 5
LB - Libano 5
CL - Cile 4
ET - Etiopia 4
EU - Europa 4
GT - Guatemala 4
IR - Iran 4
MA - Marocco 4
TH - Thailandia 4
KE - Kenya 3
KZ - Kazakistan 3
MK - Macedonia 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
AO - Angola 2
BH - Bahrain 2
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KW - Kuwait 2
MT - Malta 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BT - Bhutan 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ML - Mali 1
MN - Mongolia 1
Totale 8.014
Città #
Singapore 751
Perugia 406
Chandler 329
Hong Kong 304
Dublin 282
San Jose 245
Ashburn 211
Dong Ket 167
Bucharest 155
San Mateo 140
Boardman 123
Santa Clara 119
Beijing 114
Munich 93
Los Angeles 81
Moscow 81
Redmond 77
Wilmington 66
Medford 58
Princeton 57
Lauterbourg 56
Altamura 55
Ann Arbor 54
Seoul 44
Lawrence 42
Brussels 40
Andover 39
New York 39
Council Bluffs 37
Jacksonville 35
Ho Chi Minh City 34
The Dalles 33
Dallas 28
Des Moines 27
Pisa 26
Chicago 25
Helsinki 25
Turku 23
Hanoi 22
Chennai 21
Phoenix 21
Rome 21
Falls Church 20
Tokyo 20
Dearborn 18
Olomouc 18
Denver 17
Montreal 17
Orem 17
Piscataway 17
Redwood City 17
Saint Petersburg 16
Brno 15
São Paulo 15
Columbus 14
West Jordan 14
Atlanta 13
Frankfurt am Main 13
Fremont 13
Johannesburg 13
Nuremberg 13
Toronto 13
Norwalk 12
San Paolo di Civitate 12
Warsaw 12
Chiajna 11
Enfield 11
Guangzhou 11
Izmir 11
Milan 11
Poplar 11
Stockholm 11
Haiphong 10
Lappeenranta 10
Manchester 10
Măgurele 10
Terni 10
Amsterdam 9
Boston 9
Brooklyn 9
Hefei 9
Houston 9
London 9
Woodbridge 9
Bologna 8
Da Nang 8
Mexico City 8
Mumbai 8
Nanjing 8
Querétaro 8
San Francisco 8
Abidjan 7
Buenos Aires 7
Rio de Janeiro 7
Riyadh 7
Vicenza 7
Athens 6
Baku 6
Caracas 6
City of London 6
Totale 5.260
Nome #
Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1 228
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 213
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 205
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 202
Amino-acid sensing and degrading pathways in immune regulation 198
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 190
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 187
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 184
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 182
Amino acid metabolism as drug target in autoimmune diseases 180
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 175
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 162
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 162
88P - Relationship between functions and intracellular localization of the immune checkpoint target indoleamine 2, 3-dioxygenase 1 154
LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism 148
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 145
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 143
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 140
The TGF-β/IDO axis in infectious tolerance. 138
Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine 137
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 137
The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors 135
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 132
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 128
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 125
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation 124
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells 123
AhR-Mediated, Non-Genomic Modulation of IDO1 Function 122
Amino acid metabolism in rheumatoid arthritis: Friend or foe? 120
Different partners, opposite outcomes: A New Perspective of the Immunobiology of Indoleamine 2,3-Dioxygenase 118
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 116
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 115
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 114
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 112
Unconventional Pathways of Protein Secretion: Mammals vs. Plants 110
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 108
Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity 108
WESTERN BLOT IDENTIFICATION OF NPM1 LEUKEMIC MUTANTS IN CYTOLOGICAL AML SAMPLES: A POWERFUL DIAGNOSTIC TECHNIQUE 107
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 106
Extracellular Vesicles in Aging: An Emerging Hallmark? 105
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 101
Reinstalling immune regulatory tryptophan catabolism in juvenile diabetes via interleukin 6 receptor blockade 100
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 100
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 98
Human Indoleamine 2,3-dioxygenase 1 (IDO1) Expressed in Plant Cells Induces Kynurenine Production 96
CTLA-4-immunoglobulin and indoleamine 2,3 dioxygenase in dominant tolerance. 96
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 94
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 93
Wolfram syndrome, a rare neurodegenerative disease: From pathogenesis to future treatment perspectives 93
IDO1 and TGF-β mediate protective effects of IFN-α in antigen-induced arthritis 90
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1 89
Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme 88
Sensing of an HIV-1-Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance 87
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 85
Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3). 84
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 84
Topical application of soluble CD83 induces IDO-mediated immune modulation, increases foxp3+ T cells, and prolongs allogeneic corneal graft survival 79
FGF2 and IL-1β - explorers of unconventional secretory pathways at a glance 79
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 78
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 78
Unconventional Transport Routes of Soluble and Membrane Proteins and Their Role in Developmental Biology 78
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 72
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 66
Moonlighting Proteins Are Important Players in Cancer Immunology 65
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 62
Vedere per credere: utilizzo della microscopia per lo studio dell’immunologia 61
Western blot identification of NPM1 leukemic mutants in cytological AML samples: A powerful diagnostic technique 57
GLP-1 receptor agonists as promising disease-modifying agents in WFS1 spectrum disorder 52
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 51
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 50
Adverse pro-tumorigenic effects of IDO1 catalytic inhibitors mediated by the non-enzymatic function of IDO1 in tumor cells 29
Gallic acid released by a layered double hydroxide-coated scaffold of hydroxyapatite and β-tricalcium phosphate inhibits the osteoclast formation In Vitro 27
Totale 8.300
Categoria #
all - tutte 34.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.709


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022747 0 0 15 18 28 17 6 153 101 116 94 199
2022/20231.122 61 190 16 84 105 99 2 64 388 14 87 12
2023/2024607 27 69 21 13 8 11 158 18 42 35 65 140
2024/20251.301 21 98 57 107 124 87 104 141 212 71 171 108
2025/20262.905 166 181 168 364 389 305 474 189 297 235 82 55
2026/2027222 71 100 51 0 0 0 0 0 0 0 0 0
Totale 8.300